C. Schiefler

Inhibition of SphK1 reduces radiation-induced migration and enhances sensitivity to cetuximab treatment by affecting the EGFR/SphK1 crosstalk

G. Piontek, M. Rudelius, G. Brockhoff, 2014, Oncotarget.